In this article, we will explore stocks that Billionaire Druckenmiller and Jim Cramer like.
Stanley Druckenmiller and Jim Cramer are two of the closely followed voices in financial markets. Though sometimes their stock preferences differ, they always draw widespread investor attention. Druckenmiller is known for his role alongside George Soros during the 1992 pound trade. He manages his personal wealth through the Duquesne Family Office, after closing his legendary Duquesne Capital Management hedge fund in 2010. The billionaire investor has built a reputation for macro-driven investing alongside concentrated bets. Meanwhile, Cramer found his stardom through his platform on CNBC, where he regularly interpreted corporate developments, earnings trends, and sector rotations for a broad audience. Cramer is known for highlighting stocks that he believes reflect changing economic conditions.
The specific equities that have received nods from both of these seasoned investors are highly significant, especially in the current period. According to a CNBC article, the broader market is fixated on the Federal Reserve’s leadership transition and a steady 3% inflation rate as of April 28, 2026. The Federal Open Market Committee (FOMC) prepares for its latest interest rate decision on April 29, 2026, but some, including Goldman Sachs, anticipate that policy guidance will remain unchanged despite better labor market news. On the other hand, crude oil prices continue to hover around $100 a barrel as of late April 2026, complicating the decisions for the Fed and even for investors.
With these developments increasing the need for guidance from expert investors, we have compiled a list of 10 stocks that have garnered positive views from two of the biggest names in the market: Billionaire Druckenmiller and Jim Cramer.
Stay with us as we count down our top picks from 10 to 1.
Our Methodology
We have compiled a list of stocks favored by Billionaire Druckenmiller and Jim Cramer by reviewing the experts’ statements in the media. We ranked these stocks by the number of hedge funds holding a stake in each. The fourth-quarter hedge fund data available in the Insider Monkey database has been used for this purpose. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. All the pricing data are current as of market close on April 30, 2026.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10. Restaurant Brands International Inc. (NYSE:QSR)
Number of Hedge Fund Holders: 36
Restaurant Brands International Inc. (NYSE:QSR) is among the stocks that Billionaire Druckenmiller and Jim Cramer like.
Restaurant Brands International Inc. (NYSE:QSR) saw its price target increase on April 28, 2026. Scotiabank raised its price target on the stock from $71 to $81 while maintaining a Sector Perform rating. The intense unit growth targets amid macro and consumer pressure have made the firm take a moderately cautious approach toward the stock. According to the firm’s analyst, John Zamparo, further upside in the stock is possible, but only after clearer evidence of sustained growth.
Similar to this adjustment, on April 24, 2026, Bank of America also raised its price target on Restaurant Brands International Inc. (NYSE:QSR) from $63 to $74. The firm reiterated an Underperform rating on the company’s stock. BofA is revising its estimates and price targets across the restaurant sector ahead of first-quarter earnings reports. Notably, Restaurant Brands International Inc. (NYSE:QSR) announced earlier in April that it will report its first-quarter 2026 earnings results on May 6, 2026.
The stock appears in Druckenmiller’s portfolio as a top dividend-paying holding, and was praised by Cramer for its performance last year.
Founded in 2014, Restaurant Brands International Inc. (NYSE:QSR) is one of the world’s largest quick-service restaurant companies in the world. Based in Ontario, Canada, the company owns and operates four iconic brands: Burger King, Tim Hortons, Popeyes Louisiana Kitchen, and Firehouse Subs.
9. Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Number of Hedge Fund Holders: 60
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is among the stocks that Billionaire Druckenmiller and Jim Cramer like.
On April 29, 2026, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced entering into a definitive agreement to acquire Emalex Biosciences. The transaction involves $700 million in cash, plus up to $200 million in milestone payments and royalties. Through the acquisition, the company gains access to ecopipam, a first-in-class selective dopamine D1 receptor antagonist for pediatric Tourette syndrome. Following positive Phase 3 results, ecopipam awaits an NDA in the second half of 2026. The transaction is anticipated to close by Q3 2026, with Teva Pharmaceutical Industries Limited (NYSE:TEVA) maintaining its 2027 financial targets despite the near-term investment.
Separately, Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported its Q1 2026 earnings results on April 29, 2026, highlighting a 2% increase in revenue year-over-year to approximately $4 billion in USD. The company attributes the increase to its innovative portfolio growth and disciplined execution, despite facing headwinds in lenalidomide capsules. The company’s non-GAAP EPS of $0.53 surpassed the consensus estimate of $0.48 – $0.50.
Druckenmiller built a multi-quarter position on the stock before trimming in Q4 2025, while Cramer reversed his long-held skepticism and hosted the CEO in January 2026, praising a genuine turnaround.
The company brought in a new leader, Richard Francis, at the beginning of 2023, and the stock hasn’t looked back since, nearly 400% gain from its 2022 lows.
Founded in 1901, Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a leading innovative biopharmaceutical company. The Israel-based company focuses on developing, manufacturing, marketing, and distributing generic and other medicines and biopharmaceutical products.
8. Woodward, Inc. (NASDAQ:WWD)
Number of Hedge Fund Holders: 69
Woodward, Inc. (NASDAQ:WWD) is among the stocks that Billionaire Druckenmiller and Jim Cramer like.
On April 21, 2026, Woodward, Inc. (NASDAQ:WWD) entered an Elite Licensed Repair Service Facility Agreement (LRSF) with Lufthansa Technik, designating it as the company’s first Elite-level Licensed Repair Service Facility for CFM LEAP engine controls. As per the agreement, Lufthansa Technik is authorized to provide repair and overhaul services for Woodward, Inc. (NASDAQ:WWD)’s fuel controls, valves, and actuators on Airbus A320neo and Boeing 737 MAX aircraft. Part of the collaboration also involves Lufthansa Technik investing in advanced tooling and equipment tests to enable full Elite-level capabilities for Woodward components. John DiSilvestro, Senior Vice President of Sales, Marketing, and Service, Woodward, Inc. (NASDAQ:WWD), stated:
Lufthansa Technik is a proven leader in engine and component maintenance and a trusted partner. Together, we are strengthening global support for the growing CFM LEAP engine fleet.
Woodward, Inc. (NASDAQ:WWD) signed another LRSF agreement, on April 23, 2026, with AFI KLM E&M to support CFM LEAP-1A and 1B engines. The agreement authorizes AFI KLM E&M to provide full MRO services for critical fuel controls and actuators, thereby allowing the partnership to enhance global fleet availability and turnaround times for next-generation aircraft.
The stock still holds a top-tier slot in the Duquesne portfolio as of Q4 2025 and is praised by Cramer as a “high-quality, profitable company”.
Founded in 1870, Woodward, Inc. (NASDAQ:WWD) is a global leader in the design and manufacture of energy control solutions. Based in Colorado, the company serves the aerospace and industrial markets with systems that optimize performance in tough environments.
7. Natera, Inc. (NASDAQ:NTRA)
Number of Hedge Fund Holders: 74
Natera, Inc. (NASDAQ:NTRA) is among the stocks that Billionaire Druckenmiller and Jim Cramer like.
William Blair initiated coverage of Natera, Inc. (NASDAQ:NTRA) with an Outperform rating on the company’s stock on April 14, 2026. The firm recommends the stock as a core, long-term growth holding. William Blair highlights Natera, Inc. (NASDAQ:NTRA)’s leadership in major diagnostic markets and its diversified, expanding portfolio, positioning the company as a top investment choice in the medical technology sector.
Separately, on April 13, 2026, Natera, Inc. (NASDAQ:NTRA) highlighted positive interim results from Allogene Therapeutics’ (ALLO) registrational ALPHA3 trial, which uses the company’s CLARITY MRD assay. The study evaluates cema-cel CAR T therapy in patients with large B-cell lymphoma who remain positive for molecular residual disease (MRD) after initial treatment. Analysis showed 58.3% of MRD-positive patients achieved clearance with cema-cel. Median plasma ctDNA levels went down 97.7% in the treatment arm, compared to a 26.6% increase in the observation group. These findings offer early evidence of drug performance and reflect Natera, Inc. (NASDAQ:NTRA)’s phased variant technology in identifying high-risk patients.
Notably, the fourth quarter of 2025 established the stock as the largest holding at 12.8% of Druckenmiller’s portfolio. While acknowledging its growth in diagnostic testing, Jim Cramer takes a cautious view of the company.
Founded in 2003, Natera, Inc. (NASDAQ:NTRA) is a leader in cell-free DNA (cfDNA) and genetic testing. The Texas-based company specializes in high-sensitivity molecular diagnostics across three primary domains: women’s health (NIPT), oncology (MRD), and organ health (transplant rejection).
6. Insmed Incorporated (NASDAQ:INSM)
Number of Hedge Fund Holders: 75
Insmed Incorporated (NASDAQ:INSM) is among the stocks that Billionaire Druckenmiller and Jim Cramer like.
On April 9, 2026, Raymond James initiated coverage of Insmed Incorporated (NASDAQ:INSM) with an Outperform rating. The firm’s analyst set a price target of $200 on the stock. According to the analyst’s research note, the early launch of Brinsupri has materially de-risked the company’s trajectory. The firm described it as one of the strongest inflammation and immunology debuts ever and cited a massive underserved market and limited competition for the drug.
In a separate development, on April 14, 2026, RBC Capital raised its price target on Insmed Incorporated (NASDAQ:INSM) from $212 to $216 while maintaining an Outperform rating on the company’s stock. RBC Capital told investors that, in a survey of 50 physicians conducted by the firm, high satisfaction was noted with Brinsupri’s clinical profile. Physicians expect to significantly increase prescriptions, noting that the eligible patient population is expanding dramatically. With these findings, the analyst believes the drug’s strong growth in the immunology market is reinforced.
Druckenmiller has been one of the most aggressive accumulators of Insmed Incorporated (NASDAQ:INSM) across consecutive quarters, building it into a top-three position, while Cramer believes that the stock is worth following:
Still, this one is worth keeping an eye on.
Founded in 1988, Insmed Incorporated (NASDAQ:INSM) is a global biopharmaceutical company. Headquartered in New Jersey, the company specializes in pulmonary conditions, particularly those involving chronic airway inflammation and infectious diseases.
While we acknowledge the potential of INSM to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than INSM and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the Billionaire Druckenmiller and Jim Cramer Like These Stocks – Top 5.
Disclosure: None. Follow Insider Monkey on Google News.
